Verition Fund Management LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $476,352 - $590,208	-6,400 Reduced 26.78%	17,500 $1.44 Million
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $1.51 Million - $1.78 Million	18,000 Added 305.08%	23,900 $2.09 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $449,698 - $581,209	5,900 New	5,900 $568,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $894,948 - $1.2 Million	10,200 New	10,200 $991,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $203,877 - $228,933	-2,700 Reduced 35.06%	5,000 $417,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.81 Million - $2.44 Million	-28,200 Reduced 78.55%	7,700 $651,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $1.31 Million - $1.53 Million	15,500 Added 75.98%	35,900 $3.19 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $1.63 Million - $2.16 Million	20,400 New	20,400 $1.74 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.